The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer
Open accessAbstract
Tumor-infiltrating B-cells (TIL-B) in breast cancer (BC) have previously been associated with improved clinical outcomes; however, their role(s) in tumor immunity is not currently well known. This study confirms and extends the correlation between higher TIL-B densities and positive outcomes through an analysis of HER2-positive and triple-negative BC patients from the BIG 02-98 clinical trial (10yr mean follow-up). Fresh tissue analyses identify an increase in TIL-B density in untreated primary BC compared to normal breast tissues, which is associated with global, CD4+ and CD8+ TIL, higher tumor grades, higher proliferation and hormone receptor negativity. All B-cell differentiation stages are detectable but significant increases in memory TIL-B are consistently present. BC with higher infiltrates are specifically characterized by germinal center TIL-B, which in turn are correlated with TFH TIL and antibody-secreting TIL-B principally located in tertiary lymphoid structures. Some TIL-B also interact directly with tumor cells. Functional analyses reveal TIL-B are responsive to BCR stimulation ex vivo, express activation markers and produce cytokines and immunoglobulins despite reduced expression of the antigen-presenting molecules HLA-DR and CD40. Overall, these data support the concept that ongoing humoral immune responses are generated by TIL-B and help to generate effective anti-tumor immunity at the tumor site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., & Browning, J. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1697 · Cited by 1,480
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Adams, S., Gray, R. J., Demaria, S., Goldstein, L., Perez, E. A., Shulman, L. N., Martino, S., Wang, M., Jones, V. E., Saphner, T. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0491 · Cited by 1,299
Loi, S., Michiels, S., Salgado, R., Sirtaine, N., Jose, V., Fumagalli, D., Kellokumpu-Lehtinen, P.-L., Bono, P., Kataja, V., Desmedt, C., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu112 · Cited by 1,256
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Gu-Trantien, C., Loi, S., Garaud, S., Equeter, C., Libin, M., de Wind, A., Ravoet, M., Le Buanec, H., Sibille, C., Manfouo-Foutsop, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67428 · Cited by 1,070
Self-citationDieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Moir, S., Ho, J., Malaspina, A., Wang, W., DiPoto, A. C., O'Shea, M. A., Roby, G., Kottilil, S., Arthos, J., Proschan, M. A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072683 · Cited by 901
Reciprocal regulation of polarized cytokine production by effector B and T cells
Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., Johnson, L. L., Swain, S. L., & Lund, F. E. (2000) · Nature Immunology · doi:10.1038/82717 · Cited by 839
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Hengstler, J. G., Kölbl, H., & Gehrmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 836
Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Gallimore, A., Glithero, A., Godkin, A., Tissot, A. C., Plückthun, A., Elliott, T., Hengartner, H., & Zinkernagel, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1383 · Cited by 763
Baff Mediates Survival of Peripheral Immature B Lymphocytes
Batten, M., Groom, J., Cachero, T. G., Qian, F., Schneider, P., Tschopp, J., Browning, J. L., & Mackay, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1453 · Cited by 704
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Lund, F. E., & Randall, T. D. (2010) · Nature Reviews Immunology · doi:10.1038/nri2729 · Cited by 638
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Nielsen, J. S., Sahota, R. A., Milne, K., Kost, S. E., Nesslinger, N. J., Watson, P. H., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0234 · Cited by 553
Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.
Disis, M. L., Calenoff, E., McLaughlin, G., Murphy, A. E., Chen, W., Groner, B., Jeschke, M., Lydon, N., McGlynn, E., & Livingston, R. B. (1994) · PubMed · Cited by 524
Giraldo, N. A., Becht, E., Pagès, F., Skliris, G., Verkarre, V., Vano, Y., Mejean, A., Saint-Aubert, N., Lacroix, L., Natario, I., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2926 · Cited by 507
Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer
Wouters, M. C. A., & Nelson, B. H. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1481 · Cited by 495
Leukocyte composition of human breast cancer
Ruffell, B., Au, A., Rugo, H. S., Esserman, L. J., Hwang, E. S., & Coussens, L. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104303108 · Cited by 479
Milne, K., Köbel, M., Kalloger, S. E., Barnes, R. O., Gao, D., Gilks, C. B., Watson, P. H., & Nelson, B. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006412 · Cited by 446
Sautès-Fridman, C., Lawand, M., Giraldo, N. A., Kaplon, H., Germain, C., Fridman, W. H., & Dieu-Nosjean, M.-C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00407 · Cited by 379
Remark, R., Alifano, M., Cremer, I., Lupo, A., Dieu-Nosjean, M.-C., Riquet, M., Crozet, L., Ouakrim, H., Goc, J., Cazes, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3847 · Cited by 375
Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin
Park, S. L., Buzzai, A., Rautela, J., Hor, J. L., Hochheiser, K., Effern, M., McBain, N., Wagner, T., Edwards, J., McConville, R., et al. (2019) · Nature · doi:10.1038/s41586-018-0812-9 · Cited by 375
CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer
Gu-Trantien, C., Migliori, E., Buisseret, L., de Wind, A., Brohée, S., Garaud, S., Noël, G., Dang Chi, V. L., Lodewyckx, J.-N., Naveaux, C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91487 · Cited by 368
Self-citationHiraoka, N., Ino, Y., Yamazaki-Itoh, R., Kanai, Y., Kosuge, T., & Shimada, K. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.145 · Cited by 367
DiLillo, D. J., Yanaba, K., & Tedder, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903009 · Cited by 359
West, N. R., Milne, K., Truong, P. T., Macpherson, N., Nelson, B. H., & Watson, P. H. (2011) · Breast Cancer Research · doi:10.1186/bcr3072 · Cited by 356
Portugal, S., Tipton, C. M., Sohn, H., Kone, Y., Wang, J., Li, S., Skinner, J., Virtaneva, K., Sturdevant, D. E., Porcella, S. F., et al. (2015) · eLife · doi:10.7554/elife.07218 · Cited by 329
Seo, A. N., Lee, H. J., Kim, E. J., Kim, H. J., Jang, M. H., Lee, H. E., Kim, Y. J., Kim, J. H., & Park, S. Y. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.634 · Cited by 317
Bruno, T. C., Ebner, P. J., Moore, B. L., Squalls, O. G., Waugh, K. A., Eruslanov, E. B., Singhal, S., Mitchell, J. D., Franklin, W. A., Merrick, D. T., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0075 · Cited by 301
Ladányi, A., Kiss, J., Somlai, B., Gilde, K., Fejős, Z., Mohos, A., Gaudi, I., & Tímár, J. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0286-3 · Cited by 287
Topography of cancer-associated immune cells in human solid tumors
Kather, J. N., Suarez-Carmona, M., Charoentong, P., Weis, C.-A., Hirsch, D., Bankhead, P., Horning, M., Ferber, D., Kel, I., Herpel, E., et al. (2018) · eLife · doi:10.7554/elife.36967 · Cited by 280
The prognostic significance of B lymphocytes in invasive carcinoma of the breast
Mahmoud, S. M. A., Lee, A. H. S., Paish, E. C., Macmillan, R. D., Ellis, I. O., & Green, A. R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1620-1 · Cited by 261
Prognostic impact of tumour‐infiltrating B cells and plasma cells in colorectal cancer
Berntsson, J., Nodin, B., Eberhard, J., Micke, P., & Jirström, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.30138 · Cited by 253
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
Castino, G. F., Cortese, N., Capretti, G., Serio, S., Di Caro, G., Mineri, R., Magrini, E., Grizzi, F., Cappello, P., Novelli, F., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1085147 · Cited by 246
Shi, J.-Y., Gao, Q., Wang, Z.-C., Zhou, J., Wang, X.-Y., Min, Z.-H., Shi, Y.-H., Shi, G.-M., Ding, Z.-B., Ke, A.-W., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3497 · Cited by 240
IgG4 subclass antibodies impair antitumor immunity in melanoma
Karagiannis, P., Gilbert, A. E., Josephs, D. H., Ali, N., Dodev, T., Saul, L., Correa, I., Roberts, L., Beddowes, E., Koers, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65579 · Cited by 239
Buisseret, L., Garaud, S., de Wind, A., Van den Eynden, G., Boisson, A., Solinas, C., Gu-Trantien, C., Naveaux, C., Lodewyckx, J.-N., Duvillier, H., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1257452 · Cited by 237
Self-citationLiu, S., Foulkes, W. D., Leung, S., Gao, D., Lau, S., Kos, Z., & Nielsen, T. O. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0432-8 · Cited by 236
Montfort, A., Pearce, O., Maniati, E., Vincent, B. G., Bixby, L., Böhm, S., Dowe, T., Wilkes, E. H., Chakravarty, P., Thompson, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0081 · Cited by 231
Bianchini, G., Qi, Y., Alvarez, R. H., Iwamoto, T., Coutant, C., Ibrahim, N. K., Valero, V., Cristofanilli, M., Green, M. C., Radvanyi, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2419 · Cited by 228
Shah, S., Divekar, A. A., Hilchey, S. P., Cho, H.-M., Newman, C. L., Shin, S.-U., Nechustan, H., Challita-Eid, P. M., Segal, B. M., Yi, K. H., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21177 · Cited by 227
Tissue‐resident memory T cells
Shin, H., & Iwasaki, A. (2013) · Immunological Reviews · doi:10.1111/imr.12087 · Cited by 200
Atypical memory B cells in human chronic infectious diseases: An interim report
Portugal, S., Obeng-Adjei, N., Moir, S., Crompton, P. D., & Pierce, S. K. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.07.003 · Cited by 192
An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0987-8 · Cited by 180
Coronella, J. A., Spier, C., Welch, M., Trevor, K. T., Stopeck, A. T., Villar, H., & Hersh, E. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1829 · Cited by 171
Pockaj, B. A., Basu, G. D., Pathangey, L. B., Gray, R. J., Hernandez, J. L., Gendler, S. J., & Mukherjee, P. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.05.027 · Cited by 168
Naturally occurring B-cell responses to breast cancer
Coronella-Wood, J. A., & Hersh, E. M. (2003) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0409-4 · Cited by 161
Francis, P. A., Crown, J. P., Leo, A. D., Buyse, M. E., Balil, A., Andersson, M., Nordenskjöld, B. A., Láng, I., Jakesz, R., Vorobiof, D., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm287 · Cited by 156
Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome
Garg, K., Maurer‐Granofszky, M., Griss, J., Brüggen, M., Wolf, I. H., Wagner, C., Willi, N., Mertz, K. D., & Wagner, S. N. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.03.022 · Cited by 126
Solinas, C., Garaud, S., Silva, P. D., Boisson, A., den Eynden, G. V., de Wind, A., RISSO, P., Vitória, J. R., Richard, F., Migliori, E., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01412 · Cited by 116
Self-citationKemp, T. J., Moore, J. M., & Griffith, T. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.892 · Cited by 115
Nedergaard, B. S., Ladekarl, M. B., Nyengaard, J. R., & Nielsen, K. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.089 · Cited by 115
Garaud, S., Zayakin, P., Buisseret, L., Rulle, U., Siliņa, K., de Wind, A., den Eyden, G. V., Larsimont, D., Willard-Gallo, K. E., & Linē, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02660 · Cited by 105
Self-citationCTLA-4 positive breast cancer cells suppress dendritic cells maturation and function
Chen, X., Shao, Q., Hao, S., Zhao, Z., Wang, Y., Guo, X., He, Y., Gao, W., & Mao, H. (2017) · Oncotarget · doi:10.18632/oncotarget.14626 · Cited by 102
Shen, M., Wang, J., & Ren, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00470 · Cited by 98
Plasma cells in primary melanoma. Prognostic significance and possible role of IgA
Bosisio, F. M., Wilmott, J. S., Volders, N., Mercier, M., Wouters, J., Stas, M., Blokx, W. A. M., Massi, D., Thompson, J. F., Scolyer, R. A., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.28 · Cited by 94
Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
Pinzón‐Charry, A., Ho, C. S. K., Maxwell, T., McGuckin, M. A., Schmidt, C., Furnival, C. M., Pyke, C., & López, J. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604018 · Cited by 91
Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer
Whitford, P., Mallon, E., George, W. D., & Campbell, A. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.419 · Cited by 88
Kang, S., Fedoriw, Y. D., Brenneman, E. K., Truong, Y. K.-N., Kikly, K. K., & Vilen, B. J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600281 · Cited by 87
Li, H., Borrego, F., Nagata, S., & Tolnay, M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501027 · Cited by 81
Lee, H. J., Lee, J.-J., Song, I. H., Park, I. A., Kang, J. K., Yu, J. H., Ahn, J., & Gong, G. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3438-8 · Cited by 80
Rudolf Virchow and Modern Aspects of Tumor Pathology
David, H. (1988) · Pathology - Research and Practice · doi:10.1016/s0344-0338(88)80138-9 · Cited by 78
Schlößer, H., Thelen, M., Lechner, A., Wennhold, K., Garcia-Marquez, M. A., Rothschild, S. I., Staib, E., Zander, T., Beutner, D., Gathof, B. S., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1512458 · Cited by 74
Functional Analysis of Tumor-Infiltrating Leukocytes in Breast Cancer Patients
Wong, P. Y., Staren, E. D., Tereshkova, N., et al. (1998) · Journal of Surgical Research · doi:10.1006/jsre.1998.5301 · Cited by 64
Lao, X., LIANG, Y.-J., Su, Y., ZHANG, S.-E., ZHOU, X., & Liao, G. (2016) · Oncology Letters · doi:10.3892/ol.2016.4184 · Cited by 61
FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer
Silva, P. D., Garaud, S., Solinas, C., de Wind, A., den Eyden, G. V., José, V., Gu‐Trantien, C., Migliori, E., Boisson, A., Naveaux, C., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.066 · Cited by 54
Self-citationProtective effect of naturally occurring anti-HER2 autoantibodies on breast cancer
Tabuchi, Y., Shimoda, M., Kagara, N., Naoi, Y., Tanei, T., Shimomura, A., Shimazu, K., Kim, S. J., & Noguchi, S. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3801-4 · Cited by 53
Garaud, S., Gu‐Trantien, C., Lodewyckx, J., Boisson, A., Silva, P. D., Buisseret, L., Migliori, E., Libin, M., Naveaux, C., Duvillier, H., et al. (2014) · Journal of Visualized Experiments · doi:10.3791/52392 · Cited by 34
Self-citationSchepers, E., Glorieux, G., Dhondt, A., Leybaert, L., & Vanholder, R. C. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.07.002 · Cited by 23
Suyama, T., Fukuda, Y., Soda, H., Ogawara, D., Iwasaki, K., Hara, T., Yoshida, M., Harada, T., Umemura, A., Yamaguchi, H., et al. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12644 · Cited by 12
Cited by
Lei, X., Lei, Y., Li, J.-K., Du, W.-X., Li, R.-G., Yang, J., Li, J., Li, F., & Tan, H.-B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.009 · Cited by 1,470
Tumor-infiltrating lymphocytes in the immunotherapy era
Paijens, S. T., Vledder, A., de Bruyn, M., & Nijman, H. W. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00565-9 · Cited by 880
Meylan, M., Petitprez, F., Becht, E., Bougoüin, A., Pupier, G., Calvez, A., Giglioli, I., Verkarre, V., Lacroix, G., Verneau, J., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.02.001 · Cited by 831
Fridman, W. H., Meylan, M., Petitprez, F., Sun, C.-M., Italiano, A., & Sautès-Fridman, C. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00619-z · Cited by 657
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P., & Nelson, B. H. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00466-1 · Cited by 524
Metadata
- Authors
- Garaud, S., Buisseret, L., Solinas, C., Gu-Trantien, C., de Wind, A., Van den Eynden, G., Naveaux, C., Lodewyckx, J.-N., Boisson, A., Duvillier, H., Craciun, L., Ameye, L., Veys, I., Paesmans, M., Larsimont, D., Piccart-Gebhart, M., & Willard-Gallo, K.
- Venue
- JCI Insight
- Published
- 2019-09-19
- Volume
- 4
- Issue
- 18
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W2967339341
- Cited by
- 347
- References
- 76
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.